Lung Cancer Biorepository Clinical Trials in Oklahoma City, OK

Hightower is conducting a non-interventional NSCLC biorepository study in Oklahoma City, OK, using longitudinal blood collection. The study collects clinical and molecular data from NSCLC patients throughout their standard treatment and monitoring. Blood samples are taken over time to track disease progression and explore how changes in ctDNA can help predict recurrence and treatment outcomes. Participation is free, with no insurance required. The study doctor will guide participants through the process and answer any questions to help them make an informed decision.

Hightower Clinical is conducting lung cancer diagnosis biorepository trials in Oklahoma City, OK. This prospective, multi-center, observational study aims to identify biomarkers for the early detection of lung cancer through blood screening. The trial targets participants in the U.S. aged 50 and older with a smoking history of at least 20 years. By collecting blood samples from high-risk individuals, the study seeks to validate a blood-based test for early lung cancer detection/ Participation is free, with all procedures, treatments, and investigational drugs provided at no cost. No insurance is required, and the study doctor will guide participants through the process and answer any questions before enrollment.

The Advanced Precision Observational Lung Living Outcomes (APOLLO) study aims to advance precision medicine in lung cancer by collecting detailed molecular and clinical data from patients. Its goal is to optimize treatment outcomes and develop personalized treatment strategies. Hightower’s approach emphasizes the inclusion of smokers, recognizing smoking’s critical role in lung cancer development and progression. By analyzing diverse patient profiles, the study seeks new insights into lung cancer biology. Participation is free, with no insurance required, and all procedures, including study-related treatment and investigational drugs, are provided at no cost.